Annual report pursuant to Section 13 and 15(d)

Inventories

v2.4.0.8
Inventories
12 Months Ended
Jun. 30, 2013
Inventories

D. Inventories:

Inventories consist of (in thousands):

 

     June 30,  
     2013      2012  

Raw materials

   $ 5,885       $ 5,678   

Finished goods

     28,992         32,599   
  

 

 

    

 

 

 
   $ 34,877       $ 38,277   
  

 

 

    

 

 

 

At June 30, 2013 and 2012, the Company had $26.0 million and $23.3 million, respectively, of excess protein, antibody and chemically-based inventory on hand which was not valued.